Drug resistant tuberculosis (MDR-TB)

Drug-resistant tuberculosis is a tuberculous infection caused by infectious bacteria resistant to treatment with first-line anti-tuberculosis drugs. Insufficient medication administration is the main cause of drug resistance. Some infectious tuberculosis bacteria are also resistant to second-line drugs, known as TB extensively resistant to drugs. At the beginning of treatment with antibiotics, some strains of the tuberculosis bacteria produced resistance to specific drugs through genetic changes. Multi-drug resistance requires second-line drugs, which are less effective and more active. 9% of MDR-TB are resistant to one of the group's drugs under XDR-TB. The increase in the level of resistance in the tuberculosis strain causes complications for public health in the control of tuberculosis.

    Related Conference of Drug resistant tuberculosis (MDR-TB)

    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic
    June 29-30, 2026

    7th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 25-26, 2026

    18th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands

    Drug resistant tuberculosis (MDR-TB) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in